Evidence map›Paper›PMID 36959144›Full record

ArticleCurrent molecular medicine2024

Forough Kazemi, Hemen Moradi-Sardareh, Reza Arjmand, Mehdi Tavalla, Afshin Amari, Bahman Cheraghian

Abstract read
PubMed Publisher
In one paragraph

Article in Current molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Forough KazemiStudent Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Hemen Moradi-SardarehDepartment of Basic Sciences, Asadabad School of Medical Sciences, Asadabad, Iran.
Reza ArjmandHealth Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mehdi TavallaDepartment of Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Afshin AmariCellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Bahman CheraghianAlimentary Tract Research Center, Clinical Sciences Research Institute, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Ahvaz Jundishapur University of Medical Sciences · IR

Funding

Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran OG-0043
6 · The paper itself

Abstract

introductionBreast cancer is considered the most frequent type of cancer in women with high mortality worldwide, and most importantly, it is the second most common cancer. However, some breast cancer-related risk factors remain unknown. So, the current study was designed to evaluate the effect of

methodsMice were categorized into four groups: A) control, B) treated with 4T1+

resultsThe expression of Ki-67 was significantly increased in the 4T1+

conclusionOur findings showed that

Indexed as

Breast NeoplasmsToxocara canisToxocariasisAnimalsFemaleHumansInterleukin-10Ki-67 AntigenMiceTumor Necrosis Factor-alphaTumor Suppressor Protein p53Vascular Endothelial Growth Factor AInterleukin-10Ki-67 AntigenTumor Necrosis Factor-alphaTumor Suppressor Protein p53Vascular Endothelial Growth Factor Aangiogenesisapoptosisbreast cancerinflammation<i>Toxocara canis</i>tumor size.

Identifiers

PMID36959144
OpenAlexW4353070869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.